Clinical trial

Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection…

NCT00180492 · Abbott Medical Devices, Industry · Completed

Key facts

NCT number NCT00180492
Title Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE
Official title Carotid RX ACCULINK(TM)/ACCUNET(TM) Post-Approval Trial to Uncover Unanticipated or Rare Events - CAPTURE
Lead sponsor Abbott Medical Devices, Industry
Collaborators Guidant Corporation Industry
Status Completed
Study type Interventional
Conditions Atherosclerotic Disease, Carotid
Intervention type Device
Interventions RX ACCULINK(TM) Carotid Stent System and RX ACCUNET(TM) Embolic Protection System
Enrollment 1,500
Start date Oct 1, 2004
Primary completion Dec 1, 2006
Completion Aug 1, 2007
First posted Sep 16, 2005
Last update posted Oct 29, 2008
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies